Innovus Pharma Cash Flow - Annual (OTCMKTS:INNV)

Add to My Stocks
$0.12 $0 (0%) INNV stock closing price Sep 20, 2018 (Closing)

The financial analysis of INNV requires an investor to check the cash flows for Innovus Pharma. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Innovus Pharma profits and Innovus Pharma debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Innovus Pharma stock analysis. Innovus Pharma generated $-2.36M cash from operating activities in 2017. Innovus Pharma has a negative cash and cash equivalents change of $-.

View details of Innovus Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec20172016201520142013201220112010
Net Income Cash Flow
-6.5M-13.7M-4.2M-4.82M-3.95M-0.23M-2.25M-0.06M
Depreciation Depletion Amortization Cash-Flow1.41M4.27M------
Net Increase (Decrease) in Assets Liabilities1.05M-------
Cash From (used in) Discontinued Operations--------
Other Adjustments Net1.66M6.64M1.88M2.76M2.75M-2.03M-
Net Cash from (used by) Operating Activities
-2.36M-1.78M-1.03M-0.84M-0.64M-0.23M-0.2M-0.01M
Increase (Decrease) in Prop Plant And Equipment-0.04M--0.01M-0.03M----
Acquisition Disposition of Subsidiaires--------
Increase (Decrease) in Investments--------
Other Cash Inflow (Outflow) from Investment Activities-0.01M-0.17M--0.02M----
Net Cash from (used by) Investment Activities
-0.05M-0.17M-0.01M-0.06M----
Issuance (Purchase) of Equity Shares3.31M-------
Issuance (Repayment) of Debt Securities-2.71M1M-----
Increase (Decrease) in Bank & Other Borrowings-0.15M-0.25M---0.34M---
Payment of Dividends & Other Cash Distributions--------
Other Cash from (used by) Financing Activities--0.04M-0.08M-0.08M-0.05M---
Net Cash from (used by) Financing Activities
3.12M2.73M1.09M-----
Effect of Exchange Rate Changes on Cash--------
Net Change in Cash & Cash Equivalents
----0.02M--0.01M--
Cash & Equivalents at Beginning of Year--------
Cash & Equivalents at Year End1.56M-------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

While Innovus Pharma stock price history provides the price history of a stock, Innovus Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Innovus Pharma has cash of $1.56M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Innovus Pharma stock price.
  • Cash Flow from operating activities: Innovus Pharma reported a negative operating cash flow of $-2.36M for 2017 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.05M for INNV in last 2017 report.
  • Cash flow from financing activities shows the flow of cash between Innovus Pharma and its owners and creditors and was $3.12M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Innovus Pharma Cash Flow